Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasia M Hughes

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|July 2, 2021
Therapeutic Targeting of the Leukaemia MicroenvironmentVincent Kuek, Anastasia M Hughes, Rishi S Kotecha, et al.
Cancers|May 14, 2022
The Bone Marrow Microenvironment in B-Cell Development and MalignancyAnastasia M Hughes, Vincent Kuek, Rishi S Kotecha, et al.
Scientific Reports|May 29, 2024
Murine bone-derived mesenchymal stem cells undergo molecular changes after a single passage in cultureAnastasia M Hughes, Vincent Kuek, Joyce Oommen, et al.
Frontiers in Cell and Developmental Biology|February 6, 2023
Characterization of mesenchymal stem cells in pre-B acute lymphoblastic leukemiaAnastasia M Hughes, Vincent Kuek, Joyce Oommen, et al.
Scientific Reports|November 6, 2020
The bone marrow microenvironment of pre-B acute lymphoblastic leukemia at single-cell resolutionDenise Anderson, Patrycja Skut, Anastasia M Hughes, et al.
Haematologica|January 26, 2019
Romidepsin enhances the efficacy of cytarabine <i>in vivo</i>, revealing histone deacetylase inhibition as a promising therapeutic strategy for <i>KMT2A</i>-rearranged infant acute lymphoblastic leukemiaLaurence C Cheung, Mark N Cruickshank, Anastasia M Hughes, et al.
Frontiers in Oncology|May 3, 2021
Preclinical Evaluation of Carfilzomib for Infant <i>KMT2A</i>-Rearranged Acute Lymphoblastic LeukemiaLaurence C Cheung, Rebecca de Kraa, Joyce Oommen, et al.
Leukemia|May 10, 2018
New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironmentLaurence C Cheung, Jennifer Tickner, Anastasia M Hughes, et al.
Blood Cancer Journal|February 27, 2025
Targeting osteoclasts for treatment of high-risk B-cell acute lymphoblastic leukemiaRishi S Kotecha, Sarah M Trinder, Anastasia M Hughes, et al.
Leukemia|November 15, 2022
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategyLaurence C Cheung, Carlos Aya-Bonilla, Mark N Cruickshank, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|July 2, 2021
Therapeutic Targeting of the Leukaemia MicroenvironmentVincent Kuek, Anastasia M Hughes, Rishi S Kotecha, et al.
Cancers|May 14, 2022
The Bone Marrow Microenvironment in B-Cell Development and MalignancyAnastasia M Hughes, Vincent Kuek, Rishi S Kotecha, et al.
Scientific Reports|May 29, 2024
Murine bone-derived mesenchymal stem cells undergo molecular changes after a single passage in cultureAnastasia M Hughes, Vincent Kuek, Joyce Oommen, et al.
Frontiers in Cell and Developmental Biology|February 6, 2023
Characterization of mesenchymal stem cells in pre-B acute lymphoblastic leukemiaAnastasia M Hughes, Vincent Kuek, Joyce Oommen, et al.
Scientific Reports|November 6, 2020
The bone marrow microenvironment of pre-B acute lymphoblastic leukemia at single-cell resolutionDenise Anderson, Patrycja Skut, Anastasia M Hughes, et al.
Haematologica|January 26, 2019
Romidepsin enhances the efficacy of cytarabine <i>in vivo</i>, revealing histone deacetylase inhibition as a promising therapeutic strategy for <i>KMT2A</i>-rearranged infant acute lymphoblastic leukemiaLaurence C Cheung, Mark N Cruickshank, Anastasia M Hughes, et al.
Frontiers in Oncology|May 3, 2021
Preclinical Evaluation of Carfilzomib for Infant <i>KMT2A</i>-Rearranged Acute Lymphoblastic LeukemiaLaurence C Cheung, Rebecca de Kraa, Joyce Oommen, et al.
Leukemia|May 10, 2018
New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironmentLaurence C Cheung, Jennifer Tickner, Anastasia M Hughes, et al.
Blood Cancer Journal|February 27, 2025
Targeting osteoclasts for treatment of high-risk B-cell acute lymphoblastic leukemiaRishi S Kotecha, Sarah M Trinder, Anastasia M Hughes, et al.
Leukemia|November 15, 2022
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategyLaurence C Cheung, Carlos Aya-Bonilla, Mark N Cruickshank, et al.
Pageof 1